Private Advisor Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.13M | Sell |
|
|||||
|
2025
Q1 | $13.4M | Sell |
|
|||||
|
2024
Q4 | $17.9M | Sell |
|
|||||
|
2024
Q3 | $22.2M | Buy |
|
|||||
|
2024
Q2 | $20.7M | Sell |
|
|||||
|
2024
Q1 | $21.5M | Buy |
|
|||||
|
2023
Q4 | $19.7M | Buy |
|
|||||
|
2023
Q3 | $10.3M | Buy |
|
|||||
|
2023
Q2 | $6.02M | Buy |
|
|||||
|
2023
Q1 | $4.84M | Buy |
|
|||||
|
2022
Q4 | $816K | Sell |
|
|||||
|
2022
Q3 | $4.28M | Sell |
|
|||||
|
2022
Q2 | $4.47M | Buy |
|
|||||
|
2022
Q1 | $2.9M | Sell |
|
|||||
|
2021
Q4 | $5.01M | Buy |
|
|||||
|
2021
Q3 | $4.83M | Buy |
|
|||||
|
2021
Q2 | $4.19M | Buy |
|
|||||
|
2021
Q1 | $4.15M | Sell |
|
|||||
|
2020
Q4 | $6.43M | Buy |
|
|||||
|
2020
Q3 | $3.97M | Sell |
|
|||||
|
2020
Q2 | $9.57M | Buy |
|
|||||
|
2020
Q1 | $6.29M | Buy |
|
|||||
|
2019
Q4 | $1.81M | Buy |
|
|||||
|
2019
Q3 | $1.35M | Sell |
|
|||||
|
2019
Q2 | $1.6M | Buy |
|
|||||
|
2019
Q1 | $1.63M | Buy |
|
|||||
|
2018
Q4 | $1.2M | Sell |
|
|||||
|
2018
Q3 | $2.35M | Buy |
|
|||||
|
2018
Q2 | $1.74M | Buy |
|
|||||
|
2018
Q1 | $804K | Sell |
|
|||||
|
2017
Q4 | $1.22M | Sell |
|
|||||
|
2017
Q3 | $1.83M | Buy |
|
|||||
|
2017
Q2 | $1.5M | Buy |
|
|||||
|
2017
Q1 | $590K | Buy |
|
|||||
|
2016
Q4 | $353K | Buy |
|
|||||
|
2016
Q3 | $277K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $238K | Sell |
|
|||||
|
2015
Q1 | $216K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $60K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $2.66M | Buy |
|